Variant report

Variant	nsv437342
Chromosome Location	chr3:142605233-142622834
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:465)
CpG islands
(count:978)
Chromatin interactive
region (count:18)
LncRNA
region (count:6)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:465 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr3:142605727-142606121	K562	blood:	n/a	n/a
2	ATF1	chr3:142605737-142605989	K562	blood:	n/a	n/a
3	ATF2	chr3:142607185-142607692	H1-hESC	embryonic stem cell:	n/a	n/a
4	ATF3	chr3:142605638-142606072	K562	blood:	n/a	n/a
5	BACH1	chr3:142607083-142608248	H1-hESC	embryonic stem cell:	n/a	n/a
6	BACH1	chr3:142605728-142606153	K562	blood:	n/a	chr3:142605854-142605868
7	CCNT2	chr3:142607960-142608143	K562	blood:	n/a	n/a
8	CCNT2	chr3:142607354-142607661	K562	blood:	n/a	n/a
9	CEBPB	chr3:142609712-142609819	HepG2	liver:	n/a	chr3:142609726-142609739 chr3:142609726-142609737 chr3:142609726-142609739 chr3:142609726-142609739 chr3:142609728-142609739
10	CEBPB	chr3:142615126-142615385	Hela-S3	cervix:	n/a	n/a
11	CEBPB	chr3:142606972-142607916	Hela-S3	cervix:	n/a	n/a
12	CEBPB	chr3:142609598-142609811	K562	blood:	n/a	chr3:142609726-142609739 chr3:142609726-142609737 chr3:142609726-142609739 chr3:142609726-142609739 chr3:142609728-142609739
13	CEBPB	chr3:142613503-142613739	K562	blood:	n/a	n/a
14	CEBPB	chr3:142607397-142607556	H1-hESC	embryonic stem cell:	n/a	n/a
15	CHD1	chr3:142607108-142607515	H1-hESC	embryonic stem cell:	n/a	n/a
16	CHD2	chr3:142607358-142607738	HepG2	liver:	n/a	n/a
17	CHD2	chr3:142608010-142608072	HepG2	liver:	n/a	n/a
18	CHD2	chr3:142606999-142608069	Hela-S3	cervix:	n/a	n/a
19	CHD2	chr3:142607031-142608128	H1-hESC	embryonic stem cell:	n/a	n/a
20	CREB1	chr3:142607682-142608148	A549	lung:	n/a	n/a
21	CREB1	chr3:142606929-142607790	H1-hESC	embryonic stem cell:	n/a	n/a
22	CREB1	chr3:142607015-142607495	A549	lung:	n/a	n/a
23	CREB1	chr3:142607319-142607726	H1-hESC	embryonic stem cell:	n/a	n/a
24	CTBP2	chr3:142607012-142608279	H1-hESC	embryonic stem cell:	n/a	n/a
25	CTCF	chr3:142606860-142607010	A549	lung:	n/a	n/a
26	CTCF	chr3:142607160-142607310	HMEC	breast:	n/a	n/a
27	CTCF	chr3:142607360-142607510	AG09309	skin:	n/a	n/a
28	CTCF	chr3:142607374-142607416	H1-hESC	embryonic stem cell:	n/a	n/a
29	CTCF	chr3:142607342-142607457	MCF-7	breast:	n/a	n/a
30	CTCF	chr3:142606940-142607090	BE2_C	brain:	n/a	n/a
31	CTCF	chr3:142607080-142607230	Caco-2	colon:	n/a	n/a
32	CTCF	chr3:142607130-142607179	MCF-7	breast:	n/a	n/a
33	CTCF	chr3:142608060-142608210	AG04449	skin:	n/a	chr3:142608082-142608095
34	CTCF	chr3:142607740-142607890	NHEK	skin:	n/a	n/a
35	CTCF	chr3:142607100-142607250	HEK293	kidney:	n/a	n/a
36	CTCF	chr3:142607280-142607430	RPTEC	kidney:	n/a	n/a
37	CTCF	chr3:142606960-142607110	RPTEC	kidney:	n/a	n/a
38	CTCF	chr3:142607080-142607230	HMEC	breast:	n/a	n/a
39	CTCF	chr3:142607340-142607490	BE2_C	brain:	n/a	n/a
40	CTCF	chr3:142607099-142607247	H1-hESC	embryonic stem cell:	n/a	n/a
41	CTCF	chr3:142607060-142607210	NHEK	skin:	n/a	n/a
42	CTCF	chr3:142607360-142607510	A549	lung:	n/a	n/a
43	CTCF	chr3:142607695-142607717	MCF-7	breast:	n/a	n/a
44	CTCF	chr3:142607040-142607190	WERI-Rb-1	eye:	n/a	n/a
45	CTCF	chr3:142607360-142607510	GM12875	blood:	n/a	n/a
46	CTCF	chr3:142607080-142607230	HCT-116	colon:	n/a	n/a
47	CTCF	chr3:142607320-142607470	AG10803	skin:	n/a	n/a
48	CTCF	chr3:142607739-142607886	MCF-7	breast:	n/a	n/a
49	CTCF	chr3:142607000-142607150	GM12875	blood:	n/a	n/a
50	CTCF	chr3:142607400-142607550	SK-N-SH_RA	brain:	n/a	n/a

(count:978 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:142607981-142608031	U87	brain:	n/a
2	chr3:142606818-142606868	HPAEpiC	pulmonary alveolar:	n/a
3	chr3:142607981-142608031	U87	brain:	n/a
4	chr3:142606818-142606868	HPAEpiC	pulmonary alveolar:	n/a
5	chr3:142607799-142607849	SAEC	small airway:	n/a
6	chr3:142608228-142608278	PANC-1	pancreas:	n/a
7	chr3:142608051-142608101	HepG2	liver:	n/a
8	chr3:142610864-142610914	BJ	skin:	n/a
9	chr3:142608218-142608268	HEEpiC	esophagus:	n/a
10	chr3:142608218-142608268	PFSK-1	brain:	n/a
11	chr3:142608063-142608113	AG04450	lung:	fetal
12	chr3:142608051-142608101	HPAEpiC	pulmonary alveolar:	n/a
13	chr3:142608037-142608087	AG10803	skin:	n/a
14	chr3:142607939-142607989	PFSK-1	brain:	n/a
15	chr3:142607715-142607765	LNCaP	prostate:	n/a
16	chr3:142607511-142607561	H1-hESC	embryonic stem cell:	embryo
17	chr3:142608228-142608278	ProgFib	skin:	n/a
18	chr3:142607715-142607765	SK-N-SH	brain:	n/a
19	chr3:142608037-142608087	HAEpiC	amniotic membrane:	n/a
20	chr3:142607981-142608031	PFSK-1	brain:	n/a
21	chr3:142608898-142608948	NT2-D1	testis:	n/a
22	chr3:142608051-142608101	Caco-2	colon:	n/a
23	chr3:142607981-142608031	AoSMC	blood vessel:	n/a
24	chr3:142607799-142607849	K562	blood:	n/a
25	chr3:142610864-142610914	GM12891	blood:	n/a
26	chr3:142608228-142608278	BE2_C	brain:	n/a
27	chr3:142607357-142607407	SKMC	muscle:	n/a
28	chr3:142607978-142608028	Hela-S3	cervix:	n/a
29	chr3:142607357-142607407	Caco-2	colon:	n/a
30	chr3:142608051-142608101	HCF	heart:	n/a
31	chr3:142607511-142607561	HEEpiC	esophagus:	n/a
32	chr3:142608037-142608087	AG09319	gingival:	n/a
33	chr3:142607978-142608028	HMEC	breast:	n/a
34	chr3:142607280-142607330	ProgFib	skin:	n/a
35	chr3:142607981-142608031	HRPEpiC	eye:	n/a
36	chr3:142607280-142607330	ovcar-3	ovarian:	n/a
37	chr3:142608037-142608087	HepG2	liver:	n/a
38	chr3:142608898-142608948	BE2_C	brain:	n/a
39	chr3:142610864-142610914	HUVEC	blood vessel:	n/a
40	chr3:142608037-142608087	HCPEpiC	choroid plexus:	n/a
41	chr3:142607511-142607561	HCPEpiC	choroid plexus:	n/a
42	chr3:142608037-142608087	HEEpiC	esophagus:	n/a
43	chr3:142607280-142607330	NH-A	brain:	n/a
44	chr3:142608218-142608268	AG09319	gingival:	n/a
45	chr3:142607981-142608031	NH-A	brain:	n/a
46	chr3:142606818-142606868	Hepatocyte	liver:	n/a
47	chr3:142608218-142608268	HCPEpiC	choroid plexus:	n/a
48	chr3:142607799-142607849	AoSMC	blood vessel:	n/a
49	chr3:142608898-142608948	Caco-2	colon:	n/a
50	chr3:142608218-142608268	HAEpiC	amniotic membrane:	n/a

(count:18 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:142598080..142600621-chr3:142609257..142610987,2	K562	blood:
2	chr3:73160087..73160608-chr3:142607224..142607863,2	Hela-S3	cervix:
3	chr3:142613521..142615754-chr3:142620913..142622791,2	K562	blood:
4	chr3:142606684..142610842-chr3:142612134..142615334,5	MCF-7	breast:
5	chr3:142613521..142615754-chr3:142620913..142622791,2	K562	blood:
6	chr3:142606798..142610492-chr3:142610655..142614860,4	K562	blood:
7	chr3:142605846..142608751-chr3:142718093..142722238,5	K562	blood:
8	chr3:142611367..142612951-chr3:142614638..142616165,2	MCF-7	breast:
9	chr3:142609483..142612071-chr3:142616369..142619084,2	K562	blood:
10	chr3:142296468..142299283-chr3:142609997..142611852,2	MCF-7	breast:
11	chr3:142612125..142613700-chr3:142616630..142618763,2	K562	blood:
12	chr3:142545978..142547931-chr3:142603627..142606168,2	MCF-7	breast:
13	chr3:142547623..142548524-chr3:142606430..142607428,2	MCF-7	breast:
14	chr3:142612125..142613700-chr3:142616630..142618763,2	K562	blood:
15	chr3:142591058..142593405-chr3:142604358..142606915,2	K562	blood:
16	chr3:142609483..142612071-chr3:142616369..142619084,2	K562	blood:
17	chr3:142611367..142612951-chr3:142614638..142616165,2	MCF-7	breast:
18	chr3:142617377..142619183-chr3:142718490..142721454,2	K562	blood:

(count:6 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-PAQR9-3	chr3:142607501-142607587	NONHSAT092488
2	lnc-PAQR9-3	chr3:142606511-142606619	NONHSAT092488
3	lnc-PAQR9-3	chr3:142607656-142607864	NONHSAT092487
4	lnc-PAQR9-3	chr3:142606068-142606619	NONHSAT092489
5	lnc-PAQR9-3	chr3:142607656-142607769	NONHSAT092489
6	lnc-PAQR9-3	chr3:142606511-142606619	NONHSAT092487

No data

Variant related genes	Relation type
PCOLCE2	TF binding region
PCOLCE2	CpG island
ENSG00000223247	chromatin interactions
ENSG00000268129	chromatin interactions
ENSG00000163714	chromatin interactions
ENSG00000175054	chromatin interactions
ENSG00000240950	chromatin interactions
ENSG00000163710	chromatin interactions

Extended variants
information (count: 640 )
Associated
traits (count: 51 )

Variant overlapped rSNPs/rCNVs (count:640 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2608070	chr3:142605233-142605234	Weak transcription Enhancers Genic enhancers Strong transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs568404413	chr3:142605293-142605294	Weak transcription Enhancers Genic enhancers Strong transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs535512168	chr3:142605320-142605321	Weak transcription Enhancers Genic enhancers Strong transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs56331970	chr3:142605390-142605391	Weak transcription Enhancers Genic enhancers Strong transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs567047608	chr3:142605418-142605419	Weak transcription Enhancers Flanking Active TSS Genic enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs572844640	chr3:142605435-142605436	Weak transcription Enhancers Flanking Active TSS Genic enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs540147847	chr3:142605437-142605438	Weak transcription Enhancers Flanking Active TSS Genic enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs73232771	chr3:142605449-142605450	Weak transcription Enhancers Flanking Active TSS Genic enhancers Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs566240800	chr3:142605454-142605455	Weak transcription Enhancers Flanking Active TSS Genic enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs142980388	chr3:142605467-142605468	Weak transcription Enhancers Flanking Active TSS Genic enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs544261517	chr3:142605523-142605524	Weak transcription Enhancers Flanking Active TSS Genic enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs11716897	chr3:142605556-142605557	Weak transcription Enhancers Flanking Active TSS Genic enhancers Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
13	rs529669964	chr3:142605558-142605559	Weak transcription Enhancers Flanking Active TSS Genic enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs191396586	chr3:142605587-142605588	Weak transcription Enhancers Flanking Active TSS Genic enhancers Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs560756264	chr3:142605602-142605603	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs527946444	chr3:142605639-142605640	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs552905520	chr3:142605674-142605675	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs7648216	chr3:142605780-142605781	Weak transcription Enhancers Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs147466935	chr3:142605808-142605809	Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs556193213	chr3:142605835-142605836	Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs138312014	chr3:142605838-142605839	Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs568510147	chr3:142605878-142605879	Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs183636414	chr3:142605888-142605889	Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs188582143	chr3:142605976-142605977	Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs76701754	chr3:142605990-142605991	Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs60000382	chr3:142605998-142605999	Enhancers Weak transcription Active TSS Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs397975789	chr3:142606005-142606006	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs533809607	chr3:142606014-142606015	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs35743196	chr3:142606015-142606016	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs558594890	chr3:142606054-142606055	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs11717852	chr3:142606062-142606063	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs114260755	chr3:142606070-142606071	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
33	rs556220363	chr3:142606135-142606136	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
34	rs117249616	chr3:142606161-142606162	Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
35	rs541954287	chr3:142606241-142606242	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
36	rs183450285	chr3:142606331-142606332	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
37	rs376169532	chr3:142606336-142606337	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
38	rs546482844	chr3:142606341-142606342	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Active TSS	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
39	rs73864495	chr3:142606416-142606417	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs41267849	chr3:142606460-142606461	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
41	rs550151170	chr3:142606463-142606464	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
42	rs200038456	chr3:142606467-142606468	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
43	rs370768989	chr3:142606473-142606474	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
44	rs191441183	chr3:142606485-142606486	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
45	rs372594826	chr3:142606489-142606490	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
46	rs202166234	chr3:142606492-142606493	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
47	rs79699829	chr3:142606493-142606494	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
48	rs539483125	chr3:142606523-142606524	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
49	rs201267277	chr3:142606596-142606597	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
50	rs200265284	chr3:142606602-142606603	Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent Enhancer	Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:51)

Disease	PMID	Source
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Cervical cancer	21062161	CNVD
Squamous cell cancer	20885788	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Bipolar disorder	18458673	CNVD
Breast cancer	22032731	CNVD
Breast cancer	16461572	CNVD
Neuroblastoma	17533364	CNVD
Cervical Cancer	21857958	CNVD
Melanoma	21693616	CNVD
Lung cancer	21426551	CNVD
Cancer	21637783	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oral cancer	21386901	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	22065749	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
microdeletion syndrome	22180640	CNVD
Basal cell lymphoma	21115979	CNVD
Ovarian cancer	22174824	CNVD
Colorectal cancer	18645599	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Hepatocellular carcinoma	16750200	CNVD
Lung cancer	16740712	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myelodysplastic syndrome	21251322	CNVD
Blepharophimosis-ptosis-epicanthus inversus syndrome	22067867	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
abnormal development	18461090	CNVD
Cancer	21129771	CNVD
Ovarian cancer	23621864	CNVD
Breast cancer	21364760	CNVD
Congenital anomalies of the kidney and urinary tract	20605837	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:468 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:142586000-142606600	Weak transcription	iPS-20b Cell Line	embryonic stem cell
2	chr3:142590600-142606000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
3	chr3:142596400-142605400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
4	chr3:142601000-142606000	Weak transcription	Right Atrium	heart
5	chr3:142603200-142605600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
6	chr3:142603400-142605800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
7	chr3:142603400-142607000	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
8	chr3:142603600-142607000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
9	chr3:142603800-142605600	Enhancers	Adipose Nuclei	Adipose
10	chr3:142604000-142605400	Genic enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
11	chr3:142604000-142606600	Weak transcription	Liver	Liver
12	chr3:142604200-142605400	Strong transcription	A549	lung
13	chr3:142604200-142605800	Enhancers	K562	blood
14	chr3:142604400-142606600	Weak transcription	HUES64 Cell Line	embryonic stem cell
15	chr3:142604600-142605600	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
16	chr3:142604800-142606600	Weak transcription	Right Ventricle	heart
17	chr3:142605000-142606000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
18	chr3:142605000-142607000	Weak transcription	H9 Cell Line	embryonic stem cell
19	chr3:142605200-142606800	Enhancers	Muscle Satellite Cultured Cells	--
20	chr3:142605200-142607000	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
21	chr3:142605400-142605600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
22	chr3:142605400-142605600	Genic enhancers	A549	lung
23	chr3:142605400-142605600	Active TSS	NH-A	brain
24	chr3:142605400-142606400	Enhancers	Hela-S3	cervix
25	chr3:142605400-142606800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
26	chr3:142605400-142606800	Enhancers	Osteobl	bone
27	chr3:142605400-142607200	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
28	chr3:142605600-142605800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
29	chr3:142605600-142605800	Flanking Active TSS	Adipose Nuclei	Adipose
30	chr3:142605600-142606000	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
31	chr3:142605600-142606200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
32	chr3:142605600-142606200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
33	chr3:142605600-142606200	Flanking Active TSS	A549	lung
34	chr3:142605600-142606200	Flanking Active TSS	NH-A	brain
35	chr3:142605600-142607000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
36	chr3:142605600-142607000	Enhancers	NHEK	skin
37	chr3:142605800-142606000	Enhancers	ES-I3 Cell Line	embryonic stem cell
38	chr3:142605800-142606200	Enhancers	Adipose Nuclei	Adipose
39	chr3:142605800-142606800	Enhancers	Brain Germinal Matrix	brain
40	chr3:142605800-142606800	Weak transcription	K562	blood
41	chr3:142605800-142606800	Enhancers	NHDF-Ad	bronchial
42	chr3:142605800-142607000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
43	chr3:142606000-142606400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
44	chr3:142606000-142606400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
45	chr3:142606000-142606400	Enhancers	HMEC	breast
46	chr3:142606000-142606600	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
47	chr3:142606000-142607000	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
48	chr3:142606000-142607000	Enhancers	HSMM	muscle
49	chr3:142606000-142607800	Active TSS	Right Atrium	heart
50	chr3:142606200-142606400	Bivalent Enhancer	Fetal Intestine Small	intestine

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links